Medtronic Plc announced a voluntary ... company if they noticed changes in battery life of the pump. Insulin pumps are used ...

"This may result in the pump stopping insulin delivery significantly sooner than usually expected." Medtronic said this ... consequences like hyperglycemia, diabetic ketoacidosis, or death.

Major medical device manufacturing company Medtronic has announced a US Food and Drugs Administration (FDA) class I recall of its MiniMed insulin pump system. This announcement comes during ...

Medtronic, which has operational headquarters in Fridley, has recalled 24,595 battery-operated pumps ... of diabetes that occurs when the body doesn’t have enough insulin. Class I recalls ...

Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the ... 170 reports of hyperglycemia and 11 reports of diabetic ketoacidosis since January 2023 potentially ...

Caring for your health after a diabetes diagnosis takes precision ... the New Jersey-based medical device company Medtronic ...

Thus, the pump may stop insulin delivery ... 2023 to September 2024, Medtronic reported receiving 170 reports of hyperglycemia above 400 mg/dL, and 11 reports of diabetic ketoacidosis related ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Insulin pump therapy ... novel diagnostic and therapeutic options for diabetes therapy, including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which ...

Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...